Universal Health (UHS)
NYSE:UHS
UHS Stock Chart & Stats
$184.04
$2.61(1.40%)
At close: 4:00 PM EST
$184.04
$2.61(1.40%)
Day’s Range― - ―
52-Week Range$152.33 - $246.33
Previous CloseN/A
Volume143.67K
Average Volume (3M)817.76K
Market Cap
$11.24B
Enterprise Value$17.07B
Total Cash (Recent Filing)$137.80M
Total Debt (Recent Filing)$5.51B
Price to Earnings (P/E)9.3
Beta0.67
Next Earnings
Apr 27, 2026EPS Estimate
5.41Next Dividend Ex-DateN/A
Dividend Yield0.35%
Share Statistics
EPS (TTM)5.88
Shares Outstanding53,837,856
10 Day Avg. Volume764,668
30 Day Avg. Volume817,762
Financial Highlights & Ratios
PEG Ratio0.26
Price to Book (P/B)1.91
Price to Sales (P/S)0.80
P/FCF Ratio16.32
Enterprise Value/Market Cap1.52
Enterprise Value/Revenue0.98
Enterprise Value/Gross Profit1.09
Enterprise Value/Ebitda6.22
Forecast
1Y Price Target
$246.00Price Target Upside33.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
EPS Forecast (FY)23.44
Revenue Forecast (FY)$18.48B
Bulls Say, Bears Say
Bulls Say
Acquisition And Service ExpansionTalkspace acquisition is expected to be modestly accretive to adjusted earnings and enables a virtual intensive outpatient offering that can capture post-discharge patients and expand the care continuum.
Capital Allocation And BuybacksShare repurchases are expected to remain an active capital-allocation tool alongside the acquisition, which can support the share price and signal confidence in cash flow.
Cost Synergies And Management ContinuityManagement intends to retain Talkspace leadership while cutting duplicate public-company costs to generate annual savings, supporting margin improvement if integration proceeds smoothly.
Bears Say
Acute-care Volumes And Guidance RiskAcute-care patient volumes weakened and pricing growth decelerated, contributing to weaker-than-expected results and increasing execution risk to meet guidance that assumes stronger volume recovery.
Leverage And Balance SheetThe transaction increases financial leverage due to acquisition financing, which may constrain financial flexibility and pressure the balance sheet.
Policy And Staffing RiskExpiration of a government subsidy combined with potential state behavioral-staffing rules could reduce insured patient volumes and raise ongoing staffing costs, creating meaningful headwinds for margins in affected markets.
Universal Health News
UHS FAQ
What was Universal Health’s price range in the past 12 months?
Universal Health lowest stock price was $152.33 and its highest was $246.32 in the past 12 months.
What is Universal Health’s market cap?
Universal Health’s market cap is $11.24B.
When is Universal Health’s upcoming earnings report date?
Universal Health’s upcoming earnings report date is Apr 27, 2026 which is in 28 days.
How were Universal Health’s earnings last quarter?
Universal Health released its earnings results on Feb 25, 2026. The company reported $5.88 earnings per share for the quarter, beating the consensus estimate of $5.86 by $0.02.
Is Universal Health overvalued?
According to Wall Street analysts Universal Health’s price is currently Undervalued.
Does Universal Health pay dividends?
Universal Health pays a Quarterly dividend of $0.2 which represents an annual dividend yield of 0.35%. See more information on Universal Health dividends here
What is Universal Health’s EPS estimate?
Universal Health’s EPS estimate is 5.41.
How many shares outstanding does Universal Health have?
Universal Health has 53,837,856 shares outstanding.
What happened to Universal Health’s price movement after its last earnings report?
Universal Health reported an EPS of $5.88 in its last earnings report, beating expectations of $5.86. Following the earnings report the stock price went down -11.442%.
Which hedge fund is a major shareholder of Universal Health?
Currently, no hedge funds are holding shares in UHS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Universal Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$246.00 (33.67% Upside)
$246.00 (33.67% Upside)
Blogger Sentiment
Bullish
UHS Sentiment 62%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 237.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $128.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.9%
Last 30 Days ▲ 1.4%
Last 30 Days ▲ 1.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-0.94%
12-Months-Change
Fundamentals
Return on Equity
21.03%
Trailing 12-Months
Asset Growth
7.43%
Trailing 12-Months
Company Description
Universal Health
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company operates through Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. As of February 24, 2022, it owned and/or operated 363 inpatient facilities, and 40 outpatient and other facilities located in 39 states; Washington, D.C.; the United Kingdom; and Puerto Rico. The company also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
UHS Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call balanced strong operating and financial results — double-digit revenue and EPS growth, improved acute margins, a clear growth pipeline (inpatient expansions and outpatient behavioral rollout), active buybacks and accelerated AI adoption — against several manageable but material near-term risks including a $75M exchange-related headwind, a ~$35M one-time 2026 impact from California staffing rules (with ~$30M ongoing), timing-driven cash flow/AR pressure and localized market softness. Management provided constructive 2026 guidance that incorporates these headwinds while signaling confidence in margin expansion, volume recovery and technology-enabled efficiency gains.View all UHS earnings summariesUHS Net revenue Breakdown
9.61% Medicare
10.85% Managed Medicare
12.97% Medicaid
13.27% Managed Medicaid
25.89% Managed Care (HMO and PPOs)
5.07% UK Revenue
6.41% Other patient revenue and adjustments, net
7.08% Other non-patient revenue
UHS Stock 12 Month Forecast
Average Price Target
$246.00
▲(33.67% Upside)
Technical Analysis
Ownership Overview
5.84% Insiders
31.36% Mutual Funds
25.17% Other Institutional Investors
7.91% Public Companies and
Individual Investors